Headshot of André Fenton.

André Fenton

Professor, New York University
Contributing editor, The Transmitter

André Fenton is professor of neural science and director of the Center for Neural Science at New York University. He investigates the molecular, neural, behavioral and computational aspects of memory. He studies how brains store experiences as memories, how they learn to learn, and how knowing activates relevant information without activating what is irrelevant. These investigations are founded in how the brain computes knowledge of space, particularly the locations and directions that are the framework for experience. His investigations integrate across levels of biological organization; his research uses genetic, molecular, electrophysiological, imaging, behavioral, engineering and theoretical methods. This computational psychiatry research is helping to elucidate mental dysfunction in diverse conditions, including schizophrenia, autism, and depression.

Fenton founded BioSignal Group, Corp., which commercialized an FDA-approved portable, wireless and easy-to-use platform for recording EEGs in novel medical applications. He implemented a CPAP-oxygen-helmet treatment for COVID-19 in Nigeria and other low- and middle-income countries, and he develops information technology for the patient-centric coordination of behavioral health services that is desperately needed to equitably deliver care for mental health. Fenton hosted PBS’ “NOVA Wonders,” and he chairs the National Institute of Mental Health’s Board of Scientific Counselors.

Explore more from The Transmitter

Neuro’s ark: Understanding fast foraging with star-nosed moles

“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.

By Lauren Schneider
4 February 2026 | 7 min read

Largest leucovorin-autism trial retracted

A reanalysis of the data revealed errors and failed to replicate the results.

By Claudia López Lloreda
3 February 2026 | 4 min read

NIH scraps policy that classified basic research in people as clinical trials

The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.

By Calli McMurray
3 February 2026 | 5 min read

privacy consent banner

Privacy Preference

We use cookies to provide you with the best online experience. By clicking “Accept All,” you help us understand how our site is used and enhance its performance. You can change your choice at any time. To learn more, please visit our Privacy Policy.